|
1
|
Collaborators GRF: Global, regional, and
national comparative risk assessment of 79 behavioural,
environmental and occupational, and metabolic risks or clusters of
risks, 1990–2015: A systematic analysis for the global burden of
sisease study 2015. Lancet. 388:1659–1724. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Martínez JA, Milagro FI, Claycombe KJ and
Schalinske KL: Epigenetics in adipose tissue, obesity, weight loss,
and diabetes. Adv Nutr. 5:71–81. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Nilsson EE, Sadler-Riggleman I and Skinner
MK: Environmentally induced epigenetic transgenerational
inheritance of disease. Environ Epigenet. 4:dvy0162018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Esteller M: Non-coding RNAs in human
disease. Nat Rev Genet. 12:861–874. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Vienberg S, Geiger J, Madsen S and
Dalgaard LT: MicroRNAs in metabolism. Acta Physiol (Oxf).
219:346–361. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
O'Brien KP, Ramphul E, Howard L, Gallagher
WM, Malone C, Kerin MJ and Dwyer RM: Circulating MicroRNAs in
cancer. Methods Mol Biol. 1509:123–139. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rotllan N, Price N, Pati P, Goedeke L and
Fernández-Hernando C: microRNAs in lipoprotein metabolism and
cardiometabolic disorders. Atherosclerosis. 246:352–360. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Esau C, Davis S, Murray SF, Yu XX, Pandey
SK, Pear M, Watts L, Booten SL, Graham M, McKay R, et al: miR-122
regulation of lipid metabolism revealed by in vivo antisense
targeting. Cell Metab. 3:87–98. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Janssen HL, Reesink HW, Lawitz EJ, Zeuzem
S, Rodriguez-Torres M, Patel K, van der Meer AJ, Patick AK, Chen A,
Zhou Y, et al: Treatment of HCV infection by targeting microRNA. N
Engl J Med. 368:1685–1694. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rottiers V and Näär AM: MicroRNAs in
metabolism and metabolic disorders. Nat Rev Mol Cell Biol.
13:239–250. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xie H, Lim B and Lodish HF: MicroRNAs
induced during adipogenesis that accelerate fat cell development
are downregulated in obesity. Diabetes. 58:1050–1057. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Poy MN, Hausser J, Trajkovski M, Braun M,
Collins S, Rorsman P, Zavolan M and Stoffel M: miR-375 maintains
normal pancreatic alpha- and beta-cell mass. Proc Natl Acad Sci
USA. 106:5813–5818. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
El Ouaamari A, Baroukh N, Martens GA,
Lebrun P, Pipeleers D and van Obberghen E: miR-375 targets
3′-phosphoinositide-dependent protein kinase-1 and regulates
glucose-induced biological responses in pancreatic beta-cells.
Diabetes. 57:2708–2717. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zampetaki A, Kiechl S, Drozdov I, Willeit
P, Mayr U, Prokopi M, Mayr A, Weger S, Oberhollenzer F, Bonora E,
et al: Plasma microRNA profiling reveals loss of endothelial
miR-126 and other microRNAs in type 2 diabetes. Circ Res.
107:810–817. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhu H and Leung SW: Identification of
microRNA biomarkers in type 2 diabetes: A meta-analysis of
controlled profiling studies. Diabetologia. 58:900–911. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Paraskevopoulou MD and Hatzigeorgiou AG:
Analyzing MiRNA-LncRNA interactions. Methods Mol Biol.
1402:271–286. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yamamura S, Imai-Sumida M, Tanaka Y and
Dahiya R: Interaction and cross-talk between non-coding RNAs. Cell
Mol Life Sci. 75:467–484. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Moran VA, Perera RJ and Khalil AM:
Emerging functional and mechanistic paradigms of mammalian long
non-coding RNAs. Nucleic Acids Res. 40:6391–6400. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Franco-Zorrilla JM, Valli A, Todesco M,
Mateos I, Puga MI, Rubio-Somoza I, Leyva A, Weigel D, García JA and
Paz-Ares J: Target mimicry provides a new mechanism for regulation
of microRNA activity. Nat Genet. 39:1033–1037. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang K, Sun T, Li N, Wang Y, Wang JX, Zhou
LY, Long B, Liu CY, Liu F and Li PF: MDRL lncRNA regulates the
processing of miR-484 primary transcript by targeting miR-361. PLoS
Genet. 10:e10044672014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Legnini I, Morlando M, Mangiavacchi A,
Fatica A and Bozzoni I: A feedforward regulatory loop between HuR
and the long noncoding RNA linc-MD1 controls early phases of
myogenesis. Mol Cell. 53:506–514. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chiyomaru T, Yamamura S, Fukuhara S,
Yoshino H, Kinoshita T, Majid S, Saini S, Chang I, Tanaka Y,
Enokida H, et al: Genistein inhibits prostate cancer cell growth by
targeting miR-34a and oncogenic HOTAIR. PLoS One. 8:e703722013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang J, Liu X, Wu H, Ni P, Gu Z, Qiao Y,
Chen N, Sun F and Fan Q: CREB up-regulates long non-coding RNA,
HULC expression through interaction with microRNA-372 in liver
cancer. Nucleic Acids Res. 38:5366–5383. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sathishkumar C, Prabu P, Mohan V and
Balasubramanyam M: Linking a role of lncRNAs (long non-coding RNAs)
with insulin resistance, accelerated senescence, and inflammation
in patients with type 2 diabetes. Hum Genomics. 12:412018.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ji E, Kim C, Kim W and Lee EK: Role of
long non-coding RNAs in metabolic control. Biochim Biophys Acta
Gene Regul Mech. (pii): S1874-9399(18)30460-7. 2018.
|
|
27
|
Deiters A: Small molecule modifiers of the
microRNA and RNA interference pathway. AAPS J. 12:51–60. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gumireddy K, Young DD, Xiong X, Hogenesch
JB, Huang Q and Deiters A: Small-molecule inhibitors of microrna
miR-21 function. Angew Chem Int Ed Engl. 47:7482–7484. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Huang Z, Shi J, Gao Y, Cui C, Zhang S, Li
J, Zhou Y and Cui Q: HMDD v3.0: A database for experimentally
supported human microRNA-disease associations. Nucleic Acids Res.
47:D1013–D1017. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jiang Q, Wang Y, Hao Y, Juan L, Teng M,
Zhang X, Li M, Wang G and Liu Y: miR2Disease: A manually curated
database for microRNA deregulation in human disease. Nucleic Acids
Res. 37:D98–D104. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chen X, Yin J, Qu J and Huang L: MDHGI:
Matrix decomposition and heterogeneous graph inference for
miRNA-disease association prediction. PLoS Comput Biol.
14:e10064182018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Piñero J, Bravo À, Queralt-Rosinach N,
Gutiérrez-Sacristán A, Deu-Pons J, Centeno E, García-García J, Sanz
F and Furlong LI: DisGeNET: A comprehensive platform integrating
information on human disease-associated genes and variants. Nucleic
Acids Res. 45:D833–D839. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kutmon M, Kelder T, Mandaviya P, Evelo CT
and Coort SL: CyTargetLinker: A cytoscape app to integrate
regulatory interactions in network analysis. PLoS One.
8:e821602013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Dweep H, Sticht C, Pandey P and Gretz N:
miRWalk-database: Prediction of possible miRNA binding sites by
‘walking’ the genes of three genomes. J Biomed Inform. 44:839–847.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Maere S, Heymans K and Kuiper M: BiNGO: A
cytoscape plugin to assess overrepresentation of gene ontology
categories in biological networks. Bioinformatics. 21:3448–3449.
2004. View Article : Google Scholar
|
|
37
|
Bindea G, Galon J and Mlecnik B: CluePedia
cytoscape plugin: Pathway insights using integrated experimental
and in silico data. Bioinformatics. 29:661–663. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Li JH, Liu S, Zhou H, Qu LH and Yang JH:
starBase v2.0: Decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA
interaction networks from large-scale CLIP-Seq data. Nucleic Acids
Res. 42:D92–D97. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Liu X, Wang S, Meng F, Wang J, Zhang Y,
Dai E, Yu X, Li X and Jiang W: SM2miR: A database of the
experimentally validated small molecules' effects on microRNA
expression. Bioinformatics. 29:409–411. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Rukov JL, Wilentzik R, Jaffe I, Vinther J
and Shomron N: Pharmaco-miR: Linking microRNAs and drug effects.
Brief Bioinform. 15:648–659. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Fan Y, Siklenka K, Arora SK, Ribeiro P,
Kimmins S and Xia J: miRNet-dissecting miRNA-target interactions
and functional associations through network-based visual analysis.
Nucleic Acids Res. 44:W135–W141. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zhang T, Tan P, Wang L, Jin N, Li Y, Zhang
L, Yang H, Hu Z, Zhang L, Hu C, et al: RNALocate: A resource for
RNA subcellular localizations. Nucleic Acids Res. 45:D135–D138.
2017.PubMed/NCBI
|
|
43
|
Su ZD, Huang Y, Zhang ZY, Zhao YW, Wang D,
Chen W, Chou KC and Lin H: iLoc-lncRNA: Predict the subcellular
location of lncRNAs by incorporating octamer composition into
general PseKNC. Bioinformatics. 34:4196–4204. 2018.PubMed/NCBI
|
|
44
|
Cao Z, Pan X, Yang Y, Huang Y and Shen HB:
The lncLocator: A subcellular localization predictor for long
non-coding RNAs based on a stacked ensemble classifier.
Bioinformatics. 34:2185–2194. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Heberle H, Meirelles GV, da Silva FR,
Telles GP and Minghim R: InteractiVenn: A web-based tool for the
analysis of sets through Venn diagrams. BMC Bioinformatics.
16:1692015. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Kozomara A and Griffiths-Jones S: miRBase:
Annotating high confidence microRNAs using deep sequencing data.
Nucleic Acids Res. 42:D68–D73. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Volders PJ, Anckaert J, Verheggen K,
Nuytens J, Martens L, Mestdagh P and Vandesompele J: LNCipedia 5:
Towards a reference set of human long non-coding RNAs. Nucleic
Acids Res. 47:D135–D139. 2018. View Article : Google Scholar :
|
|
48
|
Peng C, Ye Y, Wang Z, Guan L, Bao S, Li B
and Li W: Meta-analysis of circulating microRNAs for the diagnosis
of hepatocellular carcinoma. Dig Liver Dis. 51:621–631. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Shi C, Huang F, Gu X, Zhang M, Wen J, Wang
X, You L, Cui X, Ji C and Guo X: Adipogenic miRNA and
meta-signature miRNAs involved in human adipocyte differentiation
and obesity. Oncotarget. 7:40830–40845. 2016.PubMed/NCBI
|
|
50
|
Paul P, Chakraborty A, Sarkar D, Langthasa
M, Rahman M, Bari M, Singha RS, Malakar AK and Chakraborty S:
Interplay between miRNAs and human diseases. J Cell Physiol.
233:2007–2018. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Ye D, Zhang T, Lou G, Xu W, Dong F, Chen G
and Li Y: Plasma miR-17, miR-20a, miR-20b and miR-122 as potential
biomarkers for diagnosis of NAFLD in type 2 diabetes mellitus
patients. Life Sci. 208:201–207. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Klöting N, Berthold S, Kovacs P, Schön MR,
Fasshauer M, Ruschke K, Stumvoll M and Blüher M: MicroRNA
expression in human omental and subcutaneous adipose tissue. PLoS
One. 4:e46992009. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Xiao D, Zhou T, Fu Y, Wang R, Zhang H, Li
M, Lin Y, Li Z, Xu C, Yang B, et al: MicroRNA-17 impairs glucose
metabolism in insulin-resistant skeletal muscle via repressing
glucose transporter 4 expression. Eur J Pharmacol. 838:170–176.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Heneghan HM, Miller N, McAnena OJ, O'Brien
T and Kerin MJ: Differential miRNA expression in omental adipose
tissue and in the circulation of obese patients identifies novel
metabolic biomarkers. J Clin Endocrinol Metab. 96:E846–E850. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Li H, Li T, Wang S, Wei J, Fan J, Li J,
Han Q, Liao L, Shao C and Zhao RC: miR-17-5p and miR-106a are
involved in the balance between osteogenic and adipogenic
differentiation of adipose-derived mesenchymal stem cells. Stem
Cell Res. 10:313–324. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Finnerty JR, Wang WX, Hébert SS, Wilfred
BR, Mao G and Nelson PT: The miR-15/107 group of microRNA genes:
Evolutionary biology, cellular functions, and roles in human
diseases. J Mol Biol. 402:491–509. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Trajkovski M, Hausser J, Soutschek J, Bhat
B, Akin A, Zavolan M, Heim MH and Stoffel M: MicroRNAs 103 and 107
regulate insulin sensitivity. Nature. 474:649–653. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Daimiel-Ruiz L, Klett-Mingo M,
Konstantinidou V, Micó V, Aranda JF, García B, Martínez-Botas J,
Dávalos A, Fernández-Hernando C and Ordovás JM: Dietary lipids
modulate the expression of miR-107, a miRNA that regulates the
circadian system. Mol Nutr Food Res. 59:1865–1878. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Xue X, Cao AT, Cao X, Yao S, Carlsen ED,
Soong L, Liu CG, Liu X, Liu Z, Duck LW, et al: Downregulation of
microRNA-107 in intestinal CD11c(+) myeloid cells in response to
microbiota and proinflammatory cytokines increases IL-23p19
expression. Eur J Immunol. 44:673–682. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Roggli E, Britan A, Gattesco S, Lin-Marq
N, Abderrahmani A, Meda P and Regazzi R: Involvement of microRNAs
in the cytotoxic effects exerted by proinflammatory cytokines on
pancreatic beta-cells. Diabetes. 59:978–986. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Dooley J, Garcia-Perez JE, Sreenivasan J,
Schlenner SM, Vangoitsenhoven R, Papadopoulou AS, Tian L,
Schonefeldt S, Serneels L, Deroose C, et al: The microRNA-29 family
dictates the balance between homeostatic and pathological glucose
handling in diabetes and obesity. Diabetes. 65:53–61. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Kurtz CL, Fannin EE, Toth CL, Pearson DS,
Vickers KC and Sethupathy P: Inhibition of miR-29 has a significant
lipid-lowering benefit through suppression of lipogenic programs in
liver. Sci Rep. 5:129112015. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Massart J, Sjögren RJO, Lundell LS, Mudry
JM, Franck N, O'Gorman DJ, Egan B, Zierath JR and Krook A: Altered
miR-29 expression in Type 2 diabetes influences glucose and lipid
metabolism in skeletal muscle. Diabetes. 66:1807–1818. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Chen F and Hu SJ: Effect of microRNA-34a
in cell cycle, differentiation, and apoptosis: A review. J Biochem
Mol Toxicol. 26:79–86. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Li S, Chen X, Zhang H, Liang X, Xiang Y,
Yu C, Zen K, Li Y and Zhang CY: Differential expression of
microRNAs in mouse liver under aberrant energy metabolic status. J
Lipid Res. 50:1756–1765. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Cui R, Li C, Wang J and Dai J: Induction
of hepatic miR-34a by perfluorooctanoic acid regulates
metabolism-related genes in mice. Environ Pollut. 244:270–278.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Wang J, Yan S, Zhang W, Zhang H and Dai J:
Integrated proteomic and miRNA transcriptional analysis reveals the
hepatotoxicity mechanism of PFNA exposure in mice. J Proteome Res.
14:330–341. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Shukla U, Tumma N, Gratsch T, Dombkowski A
and Novak RF: Insights into insulin-mediated regulation of CYP2E1:
miR-132/-212 targeting of CYP2E1 and role of phosphatidylinositol
3-kinase, Akt (protein kinase B), mammalian target of rapamycin
signaling in regulating miR-132/-212 and miR-122/-181a expression
in primary cultured rat hepatocytes. Drug Metab Dispos.
41:1769–1777. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Yahaya TO and Salisu TF: A review of Type
2 diabetes mellitus predisposing genes. Curr Diabetes Rev. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Go GW and Mani A: Low-density lipoprotein
receptor (LDLR) family orchestrates cholesterol homeostasis. Yale J
Biol Med. 85:19–28. 2012.PubMed/NCBI
|
|
71
|
Sun C, Zhang F, Ge X, Yan T, Chen X, Shi X
and Zhai Q: SIRT1 improves insulin sensitivity under
insulin-resistant conditions by repressing PTP1B. Cell Metab.
6:307–319. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Kauppinen A, Suuronen T, Ojala J,
Kaarniranta K and Salminen A: Antagonistic crosstalk between NF-κB
and SIRT1 in the regulation of inflammation and metabolic
disorders. Cell Signal. 25:1939–1948. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Moates JM, Nanda S, Cissell MA, Tsai MJ
and Stein R: BETA2 activates transcription from the upstream
glucokinase gene promoter in islet beta-cells and gut endocrine
cells. Diabetes. 52:403–408. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Naya FJ, Huang HP, Qiu Y, Mutoh H, DeMayo
FJ, Leiter AB and Tsai MJ: Diabetes, defective pancreatic
morphogenesis, and abnormal enteroendocrine differentiation in
BETA2/neuroD-deficient mice. Genes Dev. 11:2323–2334. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Sun W, Zu Y, Fu X and Deng Y: Knockdown of
lncRNA-XIST enhances the chemosensitivity of NSCLC cells via
suppression of autophagy. Oncol Rep. 38:3347–3354. 2017.PubMed/NCBI
|
|
76
|
van Heesch S, van Iterson M, Jacobi J,
Boymans S, Essers PB, de Bruijn E, Hao W, MacInnes AW, Cuppen E and
Simonis M: Extensive localization of long noncoding RNAs to the
cytosol and mono- and polyribosomal complexes. Genome Biol.
15:R62014. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Goff LA and Rinn JL: Linking RNA biology
to lncRNAs. Genome Res. 25:1456–1465. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Rizvi NF and Smith GF: RNA as a small
molecule druggable target. Bioorg Med Chem Lett. 27:5083–5088.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Warner KD, Hajdin CE and Weeks KM:
Principles for targeting RNA with drug-like small molecules. Nat
Rev Drug Discov. 17:547–558. 2018. View Article : Google Scholar : PubMed/NCBI
|
